Recombinant human tumor necrosis factor-related apoptosis-inducing ligand (Shenzhen Xinpeng Biotech)

重组人肿瘤坏死因子相关凋亡诱导配体（深圳新鹏生物）

Report date: 2022/04/07 15:22:14

Base Information

Drug NameRecombinant human tumor necrosis factor-related apoptosis-inducing ligand (Shenzhen Xinpeng Biotech)
Drug Alias Name重组人肿瘤坏死因子相关凋亡诱导配体（人福）TRAILTNF-related apoptosis-inducing ligand
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis stimulantsTumor necrosis factor receptor superfamily member 10B agonistsTumor necrosis factor receptor superfamily member 10A agonists
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShenzhen Sinobioway Xinpeng Biomedicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShenzhen Sinobioway Xinpeng Biomedicine Co Ltd
Inactive CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical Sciences
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A